Sign in or Register   Sign in or Register
  |  

Mouse Anti-GCH1 Recombinant Antibody (CBLG1-056) (CBMAB-G0294-LY)

This product is antibody recognizes GCH1. The antibody CBLG1-056 immunoassay techniques such as: ELISA, IHC, WB.
See all GCH1 antibodies

Summary

Host Animal
Mouse
Specificity
Human
Clone
CBLG1-056
Antibody Isotype
IgG2a
Application
ELISA, IHC, WB

Basic Information

Specificity
Human
Antibody Isotype
IgG2a
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
Liquid
Preservative
0.09% sodium azide
Purity
> 95% Purity determined by SDS-PAGE.
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freezethaw cycles.

Target

Full Name
GTP Cyclohydrolase 1
Introduction
This gene encodes a member of the GTP cyclohydrolase family. The encoded protein is the first and rate-limiting enzyme in tetrahydrobiopterin (BH4) biosynthesis, catalyzing the conversion of GTP into 7,8-dihydroneopterin triphosphate. BH4 is an essential cofactor required by aromatic amino acid hydroxylases as well as nitric oxide synthases. Mutations in this gene are associated with malignant hyperphenylalaninemia and dopa-responsive dystonia. Several alternatively spliced transcript variants encoding different isoforms have been described; however, not all variants give rise to a functional enzyme. [provided by RefSeq, Jul 2008]
Entrez Gene ID
2643
UniProt ID
P30793
Alternative Names
GTP Cyclohydrolase 1; GTP Cyclohydrolase I; Dystonia 14; EC 3.5.4.16; GTP-CH-I; DYT5; GCH; Guanosine 5-Triphosphate Cyclohydrolase I;
Function
Positively regulates nitric oxide synthesis in umbilical vein endothelial cells (HUVECs). May be involved in dopamine synthesis. May modify pain sensitivity and persistence. Isoform GCH-1 is the functional enzyme, the potential function of the enzymatically inactive isoforms remains unknown.
Biological Process
7,8-dihydroneopterin 3'-triphosphate biosynthetic process Source: UniProtKB-UniPathway
Dopamine biosynthetic process Source: UniProtKB
Negative regulation of blood pressure Source: Ensembl
Neuromuscular process controlling posture Source: MGI
Nitric oxide biosynthetic process Source: UniProtKB
Positive regulation of heart rate Source: Ensembl
Positive regulation of nitric-oxide synthase activity Source: UniProtKB
protein-containing complex assembly Source: Ensembl
Pteridine-containing compound biosynthetic process Source: UniProtKB
Regulation of blood pressure Source: UniProtKB
Regulation of lung blood pressure Source: Ensembl
Regulation of removal of superoxide radicals Source: BHF-UCL
Response to interferon-gamma Source: UniProtKB
Response to lipopolysaccharide Source: UniProtKB
Response to pain Source: UniProtKB
Response to tumor necrosis factor Source: UniProtKB
Tetrahydrobiopterin biosynthetic process Source: UniProtKB
Tetrahydrofolate biosynthetic process Source: InterPro
Vasodilation Source: Ensembl
Cellular Location
Nucleus; Cytoplasm
Involvement in disease
Hyperphenylalaninemia, BH4-deficient, B (HPABH4B):
A disease characterized by malignant hyperphenylalaninemia due to tetrahydrobiopterin deficiency, and defective neurotransmission due to depletion of the neurotransmitters dopamine and serotonin. The principal symptoms include: psychomotor retardation, tonicity disorders, convulsions, drowsiness, irritability, abnormal movements, hyperthermia, hypersalivation, and difficulty swallowing. Some patients may present a phenotype of intermediate severity between severe hyperphenylalaninemia and mild dystonia. In this intermediate phenotype, there is marked motor delay, but no mental retardation and only minimal, if any, hyperphenylalaninemia.
Dystonia, dopa-responsive (DRD):
A form of dystonia that responds to L-DOPA treatment without side effects. Dystonia is defined by the presence of sustained involuntary muscle contractions, often leading to abnormal postures. DRD typically presents in childhood with walking problems due to dystonia of the lower limbs and worsening of the dystonia towards the evening. It is characterized by postural and motor disturbances showing marked diurnal fluctuation. Torsion of the trunk is unusual. Symptoms are alleviated after sleep and aggravated by fatigue and exercise.
PTM
Phosphorylated by casein kinase II at Ser-81 in HAECs during oscillatory shear stress; phosphorylation at Ser-81 results in increased enzyme activity.
Ask a question We look forward to hearing from you.
0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Loading...
Have you used Mouse Anti-GCH1 Recombinant Antibody (CBLG1-056)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare